Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1

Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas

(2010) Mohammed Soutto et al.   CANCER

Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains

(2010) A. Jowaed et al.   JOURNAL OF NEUROSCIENCE

Conserved role of intragenic DNA methylation in regulating alternative promoters

(2010) Alika K. Maunakea et al.   NATURE

Defensins as anti-inflammatory compounds and mucosal adjuvants

(2009) Karl G Kohlgraf et al.   Future Microbiology

Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson’s disease in a Swedish population

(2009) H. Niazi Shahabi et al.   JOURNAL OF NEURAL TRANSMISSION

Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies

(2009) Rocio G Urdinguio et al.   LANCET NEUROLOGY

MPTP-induced model of Parkinson's disease in cytochrome P450 2E1knockout mice

(2009) C. Viaggi et al.   NEUROPHARMACOLOGY

Failure of neuronal homeostasis results in common neuropsychiatric phenotypes

(2008) Melissa B. Ramocki et al.   NATURE

DNA methylation landscapes: provocative insights from epigenomics

(2008) Miho M. Suzuki et al.   NATURE REVIEWS GENETICS

Cytochrome P450 2E1 in the substantia nigra: Relevance for dopaminergic neurotransmission and free radical production

(2008) H. Niazi Shahabi et al.   SYNAPSE